Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. V
6. GE
7. ASML
8. SPIR
9. NVDA
10. BSX

Go back to Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1149.36 --0 (-0%)
Previous Close $1149.36    52 Week High $88.16 
Open $1149.36    52 Week Low $67.88 
Day High $1149.36    P/E 266.06 
Day Low $1149.36    EPS $4.32 
Volume 28,564